These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8290522)

  • 1. [The clinico-immunological variants of drug-induced toxic hepatitis in pulmonary tuberculosis patients].
    Frolov VM; Peresadin NA; Petrunia AM
    Probl Tuberk; 1993; (6):17-9. PubMed ID: 8290522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of treating patients with destructive pulmonary tuberculosis with liver involvement].
    Novozhylova IO
    Lik Sprava; 1998; (7):121-3. PubMed ID: 10050479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of immunological mechanisms in chronic hepatitis.
    Eddleston AL; Williams R
    Ann Clin Res; 1976 Jun; 8(3):162-73. PubMed ID: 1087141
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of liver diseases in patients with pulmonary tuberculosis].
    El'kin AV; Ariél' BM; Nechaev VV
    Probl Tuberk; 1992; (7-8):15-8. PubMed ID: 1488430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T- and b systems of immunity in patients with newly detected destructive pulmonary tuberculosis during complex therapy].
    Kogosova LS; Bal'tseva LV; Petrashenko AI
    Probl Tuberk; 1981 Feb; (2):24-8. PubMed ID: 6972527
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment, tuberculosis, and human leukocyte antigen.
    Bothamley GH
    Am J Respir Crit Care Med; 2002 Oct; 166(7):907-8. PubMed ID: 12359643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined chemotherapy of toxic hepatitis in patients with pulmonary tuberculosis].
    Frolov VM; Peresadin NA; Pustovoĭ IuG
    Probl Tuberk; 1992; (5-6):30-1. PubMed ID: 1409510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 10. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
    Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
    Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis due to anti-tuberculous drugs.
    Aggarwal NP
    Indian J Chest Dis Allied Sci; 1992; 34(4):231-2. PubMed ID: 1302758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 13. [Functional status of lymphocytes in adolescents with tuberculosis during complex therapy].
    Nikitina OI; Skvortsova RG; Enamirovskaia AV; Slepushkin VD
    Probl Tuberk; 1987; (7):26-9. PubMed ID: 3498938
    [No Abstract]   [Full Text] [Related]  

  • 14. [Unusual therapeutic approach in treatment of pulmonary tuberculosis in six year old girl].
    Saracević E; Dizdarević A; Mulaosmanović V
    Med Arh; 2004; 58(3):183-4. PubMed ID: 15484863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical problems of tuberculostatic therapy and acute virus hepatitis.
    Schöndorf Th; leinweber B
    Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):411-8. PubMed ID: 4463666
    [No Abstract]   [Full Text] [Related]  

  • 16. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of the preparation Wobenzym on the antioxidant protection indices and on the functional-morphological properties of the erythrocytes in a toxic lesion of the liver].
    Kolomoiets MIu; Shorikov IeI
    Lik Sprava; 1999 Jul; (5):124-8. PubMed ID: 10822699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic-allergic and viral hepatitis in patients with pulmonary tuberculosis].
    Cherednichenko LP; Bessonova GS; Mikhaĭlova ES
    Probl Tuberk; 1989; (12):38-41. PubMed ID: 2628975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VA; Sokolova GB; Ziia AV; Zeliger LR; Ivleva AIa
    Ter Arkh; 1987; 59(7):75-7. PubMed ID: 3672366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.